HS Code Subheading

Medicaments; containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale

3004.39 Subheading
Section VI — Products of the chemical or allied industries

About HS Code 300439

HS 300439 is a residual category for retail-packaged medicaments containing hormones (excluding insulin and adrenal cortex hormones/corticosteroids) or their derivatives, and not containing antibiotics. This diverse category includes a wide array of hormone therapies for conditions such as thyroid disorders, hormone replacement therapy, contraception, and growth deficiencies. Products range from oral tablets and patches to injections and gels. Major pharmaceutical companies are the primary exporters, distributing these specialized medications to healthcare providers and pharmacies worldwide. The trade is characterized by specific patient populations, often requiring long-term treatment, and is subject to strict regulatory oversight due to the potent nature of hormones. Accurate classification is key to differentiate these from insulin or corticosteroid preparations, which have their own specific subheadings.

Products Under This Code

Levothyroxine sodium tablets, Estradiol patches, Testosterone gel, Progesterone capsules, Growth hormone injections, Oxytocin injections, Desmopressin tablets, Calcitonin nasal spray

Real World Examples

Synthroid, Estrace, AndroGel, Prometrium, Genotropin, Pitocin, DDAVP

Common Misclassification

Often confused with 300431 for insulin or 300432 for corticosteroids, requiring careful identification of the specific hormone type.

Products Classified Under 3004.39

Industry

This code belongs to the Chemicals industry.

Trade Overview

Major pharmaceutical manufacturing countries such as Germany, Switzerland, and the USA are key exporters, serving a global patient base.

Frequently Asked Questions

What is HS code 300439?

HS code 300439 covers: Medicaments; containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale. HS 300439 is a residual category for retail-packaged medicaments containing hormones (excluding insulin and adrenal cortex hormones/corticosteroids) or their derivatives, and not containing antibiotics. This diverse category includes a wide array of hormone therapies for conditions such as thyroid disorders, hormone replacement therapy, contraception, and growth deficiencies. Products range from oral tablets and patches to injections and gels. Major pharmaceutical companies are the primary exporters, distributing these specialized medications to healthcare providers and pharmacies worldwide. The trade is characterized by specific patient populations, often requiring long-term treatment, and is subject to strict regulatory oversight due to the potent nature of hormones. Accurate classification is key to differentiate these from insulin or corticosteroid preparations, which have their own specific subheadings.

What products fall under HS code 300439?

Levothyroxine sodium tablets, Estradiol patches, Testosterone gel, Progesterone capsules, Growth hormone injections, Oxytocin injections, Desmopressin tablets, Calcitonin nasal spray

What are common misclassifications for HS code 300439?

Often confused with 300431 for insulin or 300432 for corticosteroids, requiring careful identification of the specific hormone type.

How is HS code 300439 structured?

HS code 300439 is a 6-digit subheading under the Harmonized System. The first 2 digits (30) identify the chapter, digits 3-4 (04) identify the heading, and digits 5-6 (39) specify the subheading. This code is standardized globally by the World Customs Organization.